Your browser doesn't support javascript.
loading
An Adjusted Treatment Comparison Comparing Amivantamab Versus Real-World Clinical Practice in Europe and the United States for Patients with Advanced Non-Small Cell Lung Cancer with Activating Epidermal Growth Factor Receptor Exon 20 Insertion Mutations.
Chouaid, Christos; Bosquet, Lise; Girard, Nicolas; Kron, Anna; Scheffler, Matthias; Griesinger, Frank; Sebastian, Martin; Trigo, Jose; Viteri, Santiago; Knott, Craig; Rodrigues, Bernardo; Rahhali, Nora; Cabrieto, Jedelyn; Diels, Joris; Perualila, Nolen J; Schioppa, Claudio A; Sermon, Jan; Toueg, Raphael; Erdmann, Nicole; Mielke, Janka; Nematian-Samani, Mehregan; Martin-Fernandez, Cristina; Pfaira, Innocent; Li, Tracy; Mahadevia, Parthiv; Wolf, Jürgen.
Afiliación
  • Chouaid C; Service de Pneumologie, Pneumology, Intercommunal Hospital, 40 avenue de Verdun, 94010, Créteil, France. christos.chouaid@chicreteil.fr.
  • Bosquet L; Health Data and Partnerships Department, Unicancer, Paris, France.
  • Girard N; Institut Curie, Paris, France.
  • Kron A; Lung Cancer Group Cologne, Department I for Internal Medicine and Center for Integrated Oncology Cologne/Bonn, University Hospital Cologne, Cologne, Germany.
  • Scheffler M; Network Genomic Medicine, Cologne, Germany.
  • Griesinger F; Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Sebastian M; Lung Cancer Group Cologne, Department I for Internal Medicine and Center for Integrated Oncology Cologne/Bonn, University Hospital Cologne, Cologne, Germany.
  • Trigo J; Network Genomic Medicine, Cologne, Germany.
  • Viteri S; Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Knott C; Department of Hematology and Oncology, University Department Internal Medicine-Oncology, Pius-Hospital, University Medicine Oldenburg, Oldenburg, Germany.
  • Rodrigues B; Department of Medicine, Hematology and Oncology, University of Frankfurt, Frankfurt, Germany.
  • Rahhali N; Hospital Universitario Virgen de la Victoria y Regional, IBIMA, Malaga, Spain.
  • Cabrieto J; UOMI Cancer Center, Clínica Mi Tres Torres, Barcelona, Spain.
  • Diels J; Instituto Oncológico Dr Rosell, Hospital Universitari Dexeus, Grupo QuironSalud, Barcelona, Spain.
  • Perualila NJ; Health Data Insight CIC, Cambridge, UK.
  • Schioppa CA; National Disease Registration Service, NHS Digital, Leeds, UK.
  • Sermon J; Janssen Cilag, Porto Salvo, Portugal.
  • Toueg R; Janssen Cilag, Île-de-France, France.
  • Erdmann N; Janssen Pharmaceutica NV, Beerse, Belgium.
  • Mielke J; Janssen Pharmaceutica NV, Beerse, Belgium.
  • Nematian-Samani M; Janssen Pharmaceutica NV, Beerse, Belgium.
  • Martin-Fernandez C; Janssen Pharmaceutica NV, Beerse, Belgium.
  • Pfaira I; Janssen Pharmaceutica NV, Beerse, Belgium.
  • Li T; Janssen Cilag, Île-de-France, France.
  • Mahadevia P; Janssen-Cilag GmbH, Neuss, Germany.
  • Wolf J; Janssen-Cilag GmbH, Neuss, Germany.
Adv Ther ; 40(3): 1187-1203, 2023 03.
Article en En | MEDLINE | ID: mdl-36652175

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares / Antineoplásicos Tipo de estudio: Guideline / Prognostic_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Adv Ther Asunto de la revista: TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares / Antineoplásicos Tipo de estudio: Guideline / Prognostic_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Adv Ther Asunto de la revista: TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Estados Unidos